Dr. Travis Trent Shepherd, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 901 Center Street West Ste. A, Kimberly, ID 83341 Phone: 208-423-5001 Fax: 208-423-4867 |
Dr. Shannon Widmier, D.D. S. P.A. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 702 Center Street West, Kimberly, ID 83341 Phone: 208-423-6444 Fax: 208-423-6903 |
Dr. Kent J. Allen, D.D.S.P.A. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 702 Center Street West, Kimberly, ID 83341 Phone: 208-423-6444 Fax: 208-423-6903 |
Dr. Danton Lafey Bradshaw, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 702 Center St W, Kimberly, ID 83341 Phone: 208-423-6444 Fax: 208-423-6903 |
News Archive
It is estimated that between 1.5 million and 2 million women in this country have had breast implants since they first appeared on the market in 1962.
BravoSolution, the international leader in supply management software and services, and SciQuest, the global leader empowering enterprises to realize the potential of strategic procurement, today announced a partnership to bring their best-in-class solutions and deep industry expertise together in a one-of-a-kind source-to-settle offering for healthcare providers and life sciences organizations.
Cytori Therapeutics reported results from a preclinical cell-enriched fat grafting study supporting the safety and efficacy of Cytori's method for enriching fat grafts with adipose-derived regenerative cells (ADRCs).
Trust for America's Health and the Robert Wood Johnson Foundation today released a new report, Shortchanging America's Health: A State-By-State Look at How Public Health Dollars Are Spent, which finds federal spending for public health has been flat for nearly five years, while states around the country cut nearly $392 million for public health programs in the past year, which leaves communities around the country struggling to deliver basic disease prevention and emergency health preparedness services.
GlaxoSmithKline and ChemoCentryx, announced today that the first patient with Crohn's disease has initiated treatment in the initial pivotal induction study comparing Traficet-EN, now designated GSK1605786 ('786), to placebo.
› Verified 9 days ago